Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 22, 2002 - Issue 2
Submit an article Journal homepage
59
Views
1
CrossRef citations to date
0
Altmetric
Research Article

GYNAECOLOGY CASE REPORTS

Pages 223-230 | Published online: 02 Jul 2009

  • Chen J.-T., Hasumi K. and Masubuchi K. (1992) Maintenance of the activation of peritoneal macrophages in patients with ovarian cancer by sizofiran and recombinant Interferon- gamma. Biotherapy, 5, 137-143.
  • Hoshino T., Suzuki Y., Takeichi M., Adachi T., Yagishita M. and Takayama M. (1993) Concomitant intraperitoneal therapy with the antitumour polysaccharide Sizofiran and rG-CSF for ovarian cancer. Can To Kagaku Ryoho, 20, 1638-1641.
  • Inoue M., Tanaka Y., Sugita N., Yamasaki M., Yamanaka T., Minagawa J., Nakamuro K., Tani T., Okudaira Y., Karita T., Takayama K., Ide T. and Tanizawa O. (1993) Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy, 6, 13-18.
  • Roy W.J. Jr, Thomas B.I. and Horowitz I.R. (1997) Acute hyperglycemia following intraperitoneal irrigation with 10% dextrose in a patient with pseudomyxom a peritonei. Gynecologic Oncology, 65, 360-362.
  • Sugiyama T., Nishida T., Kumagai S., Imaishi K., Ushijima K., Kataoka A. and Yakushiji M. (1995) Combination treatment with cisplatin and schizophyllan for 7, 12-dimethylbenz(a)anthracene-induced rat ovarian adenocarcinoma. Journal of Obstetrics and Gynaecology, 21, 521-527.
  • Wertheim I., Fleischhacker D., Mclachlin C.M., Rice L.W., Berkowitz R.S. and Goff B.A. (1994) Pseudomyxoma peritonei: a review of 23 cases. Obstetrics and Gynecology, 84, 17-21.
  • Goldberg M. and Albee R. (1978) Difficult removal of an intrauterine device associated with perimenopausal uterine atrophy. Fertility and Sterility, 30, 478-479.
  • Liu P., Chow L. and Abbey H. (1972) A study of IUD retention by curve fitting. Demography, 9, 1-11.
  • Smith D. (1987) Long term IUD user at menopause. The care of a woman who wore an IUD for 14 years. Soult Dakota Journal of Medicine, 40, 5-6.
  • Sturgeon S., Brinton L., Berman M., Mortel R., Twiggs L., Barrett R., Wilbanks G. and Lurain J. (1997) Intrauterine device use and endometrial cancer risk. International Journal of Epidemiology, 26, 496-500.
  • Yeguez J., Martinez S., Sands L. and Hellinger M. (2000) Pelvic actionomycosis presenting as malignant large bowel obstruction: a case report and a review of the literature. American Surgeon, 66, 85-90.
  • Morley G.W. (1996) Treatment of uterine and vaginal prolapse. Clinical Obstetrics and Gynecology, 39, 959-969.
  • Roberg R.J., McCandlish M.M. and Dorfsman M.L. (1999) Urosepsis associated with vaginal pessary use. Annals of Emergency Medicine, 33, 581-582.
  • Sivasuriya M. (1987) Cervical entrapment of a polythene vaginal ring pessary--a clinical curiosity. Australian and New Zealand Journal of Obstetrics and Gynaecology, 27, 168-169.
  • Summers J.L. and Ford M.L. (1971) The forgotten pessary: a medical oddity. American Journal of Obstetrics and Gynecology, 111, 307-308.
  • Bines J., Oleske D.M. and Cobleigh M.A. (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. Journal tf Clinical Oncology, 14, 1718-1729.
  • Blumenfeld Z., Avivi I., Linn S., Epelbaum R., Ben-Shahar M. and Haim N. (1996) Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropin-releasin g hormone agonist in parallel to chemotherapy. Human Reproduction, 11, 1620-1626.
  • Dobson M., Carrington B.M., Radford J.A., Buckley C.H. and Crowther D. (1997) The role of computed tomography in the management of ovarian tumors of borderline malignancy. Clinical Radiology, 52, 280-283.
  • Gershenson D.M., Suva E.G., Tortolero-Luna G., Levenback C., Moms M. and Tornos C. (1998) Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer, 83, 2157-2163.
  • Gershenson D.M. (1988) Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. Journal of Clinical Oncology, 6, 270-275.
  • Massad L.S. Jr, Hunter V.J., Szpak C.A., Clarke-Pearson D.L. and Creasman W.T. (1991) Epithelial ovarian tumors of low malignant potential. Obstetrics and Oynecology, 78, 1027-1032.
  • Miyazaki T., Tomoda Y., Ohta M., Kano T., Mizuno K. and Sakakibara K. (1988) Preservation of ovarian function and reproductive ability in patients with malignant ovarian tumors. Gynecologic Oncology, 30, 329-341.
  • Altschuler L. and Valenteen J. (1974) Amenorrhoea following rifampicin administration during oral contraception use. Obstetrics and Gynaecology, 44, 771-772.
  • Anonymous (1980) Drug interaction with oral contraceptive steroids [Editorial]. British Medical Journal, 6133, 93-94.
  • Arora V.K, Bedi R.S. and Arora R. (1987) Rifampicin induced menstrual disturbances. Indian Journal of Chest Diseases and Allied Sciences, 29, 63-64.
  • Barditch-Crovo P., Trapnell C.B., Ette E, Zacur H.A., Coresh J., Rocco L.E., Hendrix C.W. and Flexner C. (1999) The effects of rifampicin and rifabutin on the phaimacokinetics and pharmacodynamics of a combination oral contraceptive. Clinical Pharmacology and Therapeutics, 65, 428-438.
  • Rose A.M., Watson J.M., Graham C., Nunn A.J., Drobniewski F., Ormerod L.P., Derbyshire J.H. and Leese J. (2001) Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax, 56, 173-179.
  • Arend W.P. Michel B.A., Bloch D.A., Hunder G.G. Calabrese L.H., Edworthy S.M. and Fauci A.S. (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu's arteritis. Arthritis and Rheumatism, 33, 1129-1134.
  • Aso T., Abe S. and Yaguchi T. (1992) Clinical gynecologic features of pregnancy in Takayasu's arteritis. Heart and Vessels, Supplement, 7, 125-132.
  • Pignon A., Mairet H., Alle C., Jacquet A., Avigdor S., Descamps P., Body G. and Lansac J. (1995) Association of Takayasu's arteritis, pregnancy and Still's disease. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 24, 747-750.
  • Kerr G.S., Hallahan C.W., Giordano J., Leavitt R.Y., Fauci A.S., Rottem M. and Hoffman G.S. (1990) Takayasu's arteritis. Annals of Internal Medicine, 120, 919-929.
  • Matsumura A., Moriwaki R. and Numano F. (1992) Pregnancy in Takayasu arteritis from the view of internal medicine. Heart and Vessels, Supplement, 7, 120-124.
  • Mosonyi A., Ludmany E., Mates L. and Czeizel E. (1996) Genetic counselling in a case of Takayasu arteritis. Orvosi-hetilap, 137, 585-587.
  • Numano F., Okawara M., Inornate H. and Kobayashi Y. (2000) Takayasu's arteritis. Lancet, 356, 1023-1025.
  • Shin D.D. and Godwin J.E. (1999) Takayasu's arteritis associated with factor V Leiden. American Journal of Hematology, 60, 237-238.
  • Armengot M., Marco J., Ruiz M. and Baixauli A. (1990) Hormones and the nasal mucosa. A bibligraphic review. Annales Otorrinolaringol Ibero Am 17, 317-328.
  • Lippincott L.H. and Amedee R.G. (1999) ENT issues in pregnancy. Journal of the Louisiana State Medical Society, 151, 350-4.
  • El Goulli M. and Chelli M. (1979) Severe epistaxis during pregnancy. A case history [author's transi]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris), 8, 437-439.
  • Reddy K., Mathews P., Goodwin R.G. and Pearson J.F. (2001) A rare case of plasman cell vulvitis (Zoon's vulvitis). Journal of Obstetrics and Gynaecology, 21, 542-543.
  • Scurry J., Dennerstein G., Brennan J., Oster A., Mason G. and Dorevitch A. (1993) Vulvitis circumscripta plasmacelluraris. A cliniopathologic entity? Journal of Reproductive Medicine, 38, 14-18.
  • Champion R.H. (1992) Rook/Wilkinson/Ebling. Textbook of Dermatology, 5th edn. pp. 1687. Oxford, Blackwell.
  • McGee J.O'D., Isaacson P.O. and Wright N.A. (1992) Oxford Textbook of Pathology, vol 2b, pp. 2148. Oxford, Oxford University Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.